Original Research
Published on 12 Sep 2022
Regular use of aspirin is associated with a lower cardiovascular risk in prostate cancer patients receiving gonadotropin-releasing hormone therapy
in Cardio-Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.952370
- 1,824 views